Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 30 June 2005. doi:10.1136/thx.2005.042564
Thorax 2005;60:773-780
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Web-only report
Right arrow All Versions of this Article:
thx.2005.042564v1
60/9/773    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raia, V
Right arrow Articles by Londei, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raia, V
Right arrow Articles by Londei, M

CYSTIC FIBROSIS

Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis

V Raia1, L Maiuri2, C Ciacci3, I Ricciardelli2, L Vacca1, S Auricchio1,4, M Cimmino5, M Cavaliere5, M Nardone5, A Cesaro5, J Malcolm2, S Quaratino6, M Londei2

1 Department of Pediatrics, University Federico II of Naples, Italy
2 Institute of Child Health, University College London, London, UK
3 Department of Gastroenterology, University Federico II of Naples, Italy
4 European Laboratory for the Investigation of Food Induced Diseases, Naples, Italy
5 Department of Otolaryngology, University Federico II of Naples, Italy
6 Cancer Research UK, Clinical Centre, Southampton General Hospital, University of Southampton, UK

Correspondence to:
Correspondence to:
Professor M Londei
Institute of Child Health, University College London, 30 Guilford Street, London WC1N 1EH, UK; m.londei{at}ich.ucl.ac.uk

Background: Cystic fibrosis (CF) airways are characterised by chronic inflammation, increased interleukin (IL)-8 secretion, and neutrophil activation which are considered the principal factors of morbidity and mortality in CF patients. Optimising management of this chronic inflammatory response is therefore a key issue of basic and clinical CF research. Several reports have addressed ways to manage CF airways inflammation, and an attractive therapeutic strategy may be the inhibition of the p38-mitogen activated protein kinase (p38-MAP-k) pathway.

Methods: A new ex vivo model was used to study the mucosal inflammatory response to environmental airways stimuli. Nasal biopsy tissues from CF patients and controls were cultured ex vivo for 20 minutes, 4 hours, and 24 hours in the presence of lipopolysaccharide (LPS) from Pseudomonas aeruginosa (PA) with and without the p38-MAP-k inhibitor SB203580. Quantitative mRNA assessment, immunohistochemistry, and Western blots were used to detect the expression and modulation of inflammatory markers.

Results: PA-LPS challenge induced a time dependent mucosal inflammation indicated by rapid epithelial activation, IL-8 release, COX-2 upregulation, and neutrophil migration to the upper mucosal layers. Some of these LPS induced changes (IL-8 release and neutrophil migration) were specific to CF tissues. SB203580 significantly controlled all LPS induced mucosal changes in CF tissues.

Conclusion: These findings provide a rationale and proof of principle for the potential use of p38-MAP-k inhibitors to control inflammation in patients with CF.


Abbreviations: CF, cystic fibrosis; IL, interleukin; LPS, lipopolysaccharide; MAP-k, mitogen activated protein kinase; PA, Pseudomonas aeruginosa

Keywords: interleukin 8; neutrophil; inflammation; cystic fibrosis; mitogen activated protein kinase




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. Maiuri, A. Luciani, I. Giardino, V. Raia, V. R. Villella, M. D'Apolito, M. Pettoello-Mantovani, S. Guido, C. Ciacci, M. Cimmino, et al.
Tissue Transglutaminase Activation Modulates Inflammation in Cystic Fibrosis via PPAR{gamma} Down-Regulation
J. Immunol., June 1, 2008; 180(11): 7697 - 7705.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Zhang, W. Reenstra, D. J. Weiner, J.-P. Louboutin, and J. M. Wilson
The p38 Mitogen-Activated Protein Kinase Signaling Pathway Is Coupled to Toll-Like Receptor 5 To Mediate Gene Regulation in Response to Pseudomonas aeruginosa Infection in Human Airway Epithelial Cells
Infect. Immun., December 1, 2007; 75(12): 5985 - 5992.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Wong, V. Korcheva, D. B. Jacoby, and B. E. Magun
Proinflammatory responses of human airway cells to ricin involve stress-activated protein kinases and NF-{kappa}B
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1385 - L1394.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society